Prospective, multicenter validation of a platform for rapid molecular profiling of central nervous system tumors

Next-day reporting of molecular diagnostic results

After a proof-of-concept preliminary version¹⁹, Rapid-CNS² was run independently at two centers on fresh or cryopreserved tumor tissue (University Hospital Heidelberg, Germany and University of…